Tiffany Tang

Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma

Tammy Song, Maarja-Liisa Nairismägi, Yurike Laurensia et al. · Blood · 2018 · 321 citations · Full text

Medicine, Cancer Biology, Oncology +17

Type II enteropathy‐associated T‐cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group

Eric Tse, Harinder Gill, Florence Loong et al. · American Journal of Hematology · 2012 · 169 citations · Full text

Medicine, Oncology, Pathology +17

Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study

Zheng Li, Yi Xia, Jie-Rong Chen et al. · The Lancet Oncology · 2016 · 96 citations

Life Sciences, Genetics, Oncology +16

Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease

Sung Hee Lim, Jung Yong Hong, Soon Thye Lim et al. · Annals of Oncology · 2017 · 92 citations · Full text

Medicine, Immunology, Oncology +16

Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group

Eric Tse, Thomas S. Y. Chan, L-P Koh et al. · Bone Marrow Transplantation · 2014 · 83 citations

Medicine, Hematology, Oncology +11